We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sucampo Snaps Up R-Tech Ueno for $278 Million
Sucampo Pharmaceuticals is paying $278 million to acquire Japanese drugmaker R-Tech Ueno, which manufactures the constipation drug Amitiza for Sucampo and its commercialization partners, Takeda, Mylan and Harbin Gloria Pharmaceuticals.